Skip to content
★ Sign in to follow
BM

Brenda Mann

Executive
VP of Research & Development
Kiora Pharmaceuticals Inc
Total declarations
35
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (3 ops.)
€4,001

Latest filing published 03 Nov 2021 for Kiora Pharmaceuticals INC, €106.

Filing timeline

BuySale
Brenda Mann

Insider track record

Disclosed buys
0
Disclosed sells
3
Signal history

Brenda Mann: trading record in brief

All filings by Brenda Mann on record concern Kiora Pharmaceuticals Inc, in the capacity of senior executive. Over a trading history stretching from 7 March 2016 to 2 November 2021, the count stands at 35 filings.

Every open-market trade on record is a sale: 3 sales worth €4,001. Besides market trades, the filings include 30 share grants.

The latest filing, published on 3 November 2021, reports a share grant of €106 in Kiora Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Brenda Mann

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations35 total

25 of 35 declarations